Role of Exercise for Wound Healing in the Larynx
1 other identifier
interventional
9
1 country
1
Brief Summary
The purpose of this study is to explore quantitatively the hypothesis that "resonant voice," may enhance recovery from acute laryngeal phonotrauma, based on molecular assays from human laryngeal secretions and secondarily, clinical tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2004
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
November 5, 2009
CompletedFirst Posted
Study publicly available on registry
November 9, 2009
CompletedNovember 9, 2009
November 1, 2009
1.1 years
November 5, 2009
November 6, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
Biomarkers in laryngeal secretions
Up to 24-hour post-baseline
Secondary Outcomes (3)
Phonation Threshold Pressure (PTP)
Up to 24-hour post baseline
Direct Magnitude Estimations of phonatory effort (DME)
Up to 24-hour post baseline
Visual-perceptual ratings of the larynx
Up to 24-hour post baseline
Study Arms (3)
Voice rest
EXPERIMENTALResonant voice exercise
EXPERIMENTALSpontaneous speech
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- males and females who have had voice training and feel they are able to produce loud voice safely;
- ages 18-49;
- generally healthy;
- normal hearing bilaterally at 20 dB to 8,000 Hz; and
- demonstrated ability to produce "resonant voice" during training as determined by the examiner perceptually.
You may not qualify if:
- current chronic voice problems;
- current medications that are determined to possibly influence voice (e.g. diuretics, decongestants);
- heightened gag reflex;
- small nasal passage;
- deviated septum; and
- known or suspected allergy to anesthetics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univesity of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine Verdolini Abbott, Ph.D.
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 5, 2009
First Posted
November 9, 2009
Study Start
February 1, 2004
Primary Completion
March 1, 2005
Study Completion
March 1, 2005
Last Updated
November 9, 2009
Record last verified: 2009-11